MedTrace Logo

Endoscopic Resection of Bladder Tumors

NCT01750970 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2016-09-21

No results posted yet for this study

Summary

To confirm the benefit of endoscopic resection under fluorescence and blue light of high grade non-muscle invasive bladder tumor, and verifying if the second endoscopic resection recommended nowadays can be deleted.

Conditions

  • Bladder Tumor

Interventions

OTHER

Endoscopic resection under blue light (Hexvix®)

Endoscopic resection

Sponsors & Collaborators

  • Hopital Foch

    lead OTHER

Principal Investigators

  • Henry BOTTO, MD · Hôpital FOCH 40, rue Worth 92150 Suresnes

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2012-12-31
Completion
2013-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01750970 on ClinicalTrials.gov